(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Crohn's Disease
This study will evaluate the safety and effectiveness of the experimental drug AST-120 to treat mild-to-moderately-severe Crohn's disease with fistulas. Candidates diagnosed with Crohn's disease -- including people with a documented diagnosis of ileitis, colitis, or ileocolitis -- who have at least one draining fistula and weigh at least 40 kg. may be eligible.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat51.html.
-----
Cervical Dysplasia
This is a clinical study of an investigational therapy for moderate-to-severe cervical dysplasia. Women between 13-25 who have had an abnormal PAP test (ASCUS, ASC-H, LSIL, HSIL) within three months and a confirmed diagnosis of CIN2/3 (confirmed at study site via biopsy) may qualify. Women will not be eligible if diagnosed with cervical carcinoma via Pap test or biopsy, or if pregnant or lactating.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat395.html.
-----
Diabetes - Type 2
This is a 26-week research study to test an experimental combination of FDA-approved medications for type 2 diabetes. Volunteers between 18 and 80 who currently use oral antidiabetic medications (metformin and a sulfonylurea) may qualify. They will receive at no cost study medications, glucose monitor and supplies, study-related medical care and testing, and compensation for time and travel to study visits.
The research site is in Dayton, Ohio.
More information
Please see http://www.centerwatch.com/patient/studies/cat603.html.
-----
Copyright 2006 CenterWatch. All rights reserved.
